GMSbiotech, Pure Protein Awarded $2.6M Grant to Develop Transplant Rejection Dx | GenomeWeb

NEW YORK (GenomeWeb) – GMSbiotech and Pure Protein announced today that they have received a $2.6 million grant from the National Institutes of Health to develop a donor-specific antibody (DSA) diagnostic for use in organ transplant patients.

The companies will combine GMSbiotech's proprietary microarray platform with soluble human leukocyte antigen proteins produced by Pure Protein. The resulting assay will be designed to analyze patients' DSA levels for the detection of antibody-mediated rejection of transplants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.